Biopsy is the technique used to extract abnormal tissue or group of cells from any part of body for analysis. Breast biopsy is mainly done to detect cancer and also used as a preventive measure. Lump or hardness in a portion of breast is taken off and tested. Breast biopsy is diagnosing method not treatment. Breast biopsy is performed by using image guidance, hollow needle and surgical manner.
Request Sample Report @ http://www.syndicatemarketresearch.com/request-for-sample.html?flag=S&repid=60649
Major market driver for breast biopsy is increasing number of female breast cancer patients that had generated awareness in society which force people to undergo check up. Breast cancer is spreading highly among the post age women is the other factor for increasing demand of breast biopsy. The region having higher population of female has high chances to fuel the market growth in that region. This diagnosis taken by middle group to elderly group is limited. High cost and specific gender are some of the factors that affect the market growth. The new developing technology in biopsy that lowers the pain and time required for the test attracts the professional females.
The report covers forecast and analysis for the breast biopsy market on global and regional level. The study provides significant data of 2014 along with estimated from 2014 to 2020 based on revenue (USD Million). The report also offers detailed competitive landscape of the global breast biopsy market. It includes company market share analysis, product portfolio of the major industry participants. The report provides detailed segmentation of the breast biopsy market based on product segment, technology segment and region.
Purchase a direct copy of report with TOC @ http://www.syndicatemarketresearch.com/market-analysis/breast-biopsy-market-global-industry-analysis-size-share.html#table-of-content
Segmentation of market is done on the basis of product, technology, and region. Product based market segmentation for breast biospy is distributed as forceps, biopsy needles, biopsy tables, biopsy charts, guidance systems, localized wires, sutures, markers, punches. Forceps and needles contributed a major share in global breast biopsy market. Increasing demand for biopsy needle and forceps will further enhance the growth of market. Different technology and methods are performed for breast biopsy. The basic methods are open surgical and needle breast biopsy. The open surgical breast biopsy is also subdivided into incisional and excisional breast biopsy. Needle breast biopsy is also further categorized into fine needle aspiration biopsy and core needle biopsy. One more technique used for breast biopsy is vacuum assisted biopsy. Vacuum assisted biopsy is most advanced, less invasion technique in which small cut is done in skin through which a needle is inserted, using vacuum to take out to the sample. Vacuum assisted biopsy technique has high demand due to its advance features.
North America dominated the global breast biopsy market due to high awareness, highly advanced and equipped instrument and technology and supportive government initiatives. Western Europe is the other leading region due to high female population, advance technology, and government programs for check up. Breast biopsy market in Asia-Pacific is also growing, due to increasing awareness among society.
The key players of breast biopsy market are Angiotech pharmaceuticals, Carefusion Corporation, Cardial Health, International Radio, DTR Medical Ltd, Brad, Hologic, and Devicor Medical Products.
The report segments the breast biopsy market into:
Breast Biopsy Market: Product Segment Analysis
- Biopsy needles
- Biopsy tables
- Biopsy charts
- Guidance systems
- Localized wires
Breast Biopsy Market: Technology Segment Analysis
- Open surgical
- Needle breast biopsy
Breast Biopsy Market: Regional Segment Analysis
- North America
- Asia Pacific
- Latin America
- Middle East & Africa